These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36068575)

  • 1. Long-term efficacy of glycopyrrolate on sialorrhea in Goldenhar syndrome: a case report.
    Della Bella G; Castelli E; Vigevano F
    Ital J Pediatr; 2022 Sep; 48(1):166. PubMed ID: 36068575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
    Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
    Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycopyrrolate for chronic drooling in children.
    Eiland LS
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycopyrrolate for drooling in children with medical complexity under three years of age.
    Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
    Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Non Invasive Treatment of Sialorrhea in the Goldenhar Syndrome.
    Marvulli R; Gallo GA; Mastromauro L; Dicuonzo F; Fiore P; Ianieri G; Megna M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):397-400. PubMed ID: 29595115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
    Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
    Trials; 2014 Feb; 15():60. PubMed ID: 24533890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
    Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N
    Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial.
    Fayoux P; Dinomais M; Shaw H; Villain F; Schwartz D; Rondeau S; Letellier G; Auvin S
    Dev Med Child Neurol; 2024 Jul; 66(7):910-918. PubMed ID: 38214675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycopyrronium for severe drooling in children.
    Drug Ther Bull; 2017 Aug; 55(8):93-96. PubMed ID: 28808084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
    Garnock-Jones KP
    Paediatr Drugs; 2012 Aug; 14(4):263-9. PubMed ID: 22646067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
    Blissit KT; Tillery E; Latham C; Pacheco-Perez J
    Am J Health Syst Pharm; 2014 Aug; 71(15):1282-7. PubMed ID: 25027535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer.
    Olsen AK; Sjøgren P
    J Pain Symptom Manage; 1999 Oct; 18(4):300-2. PubMed ID: 10534970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialorrhea - therapeutic drug options.
    Tscheng DZ
    Ann Pharmacother; 2002 Nov; 36(11):1785-90. PubMed ID: 12398577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of glycopyrrolate in the management of drooling.
    Stern LM
    J Paediatr Child Health; 1997 Feb; 33(1):52-4. PubMed ID: 9069045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In brief: Glycopyrrolate oral solution for sialorrhea.
    Med Lett Drugs Ther; 2011 Jan; 53(1355):4. PubMed ID: 21212745
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
    Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
    Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic medications for reducing drooling in children with developmental disability.
    Reid SM; Westbury C; Guzys AT; Reddihough DS
    Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Nebulized Glycopyrrolate on Posterior Drooling in Patients with Brain Injury: Two Cases of Different Brain Lesions.
    Lee ZI; Yu KJ; Lee DH; Hong SK; Woo SB; Kim JM; Park D
    Am J Phys Med Rehabil; 2017 Aug; 96(8):e155-e158. PubMed ID: 28081026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of drooling with scopolamine in pediatric ICU: A case series report.
    Franco JB; Cacita N; Freua KA; Ortega KL; de Melo Peres MPS
    Spec Care Dentist; 2018 Nov; 38(6):362-366. PubMed ID: 30238487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial.
    Fayoux P; Dinomais M; Shaw H; Probert N; Villain F; Pouchain D; Texier N; Auvin S
    BMJ Paediatr Open; 2023 May; 7(1):. PubMed ID: 37156563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.